ATXS   $11.75  4.17% Market Closed After Close 11.75 0.0

Astria Therapeutics Inc
Total Cash 354.70M
totalCashPerShare 6.286
EBITDA
Total Debt 5.79M
quickRatio 21.671
currentRatio 21.865
Total Revenue
debtToEquity 1.668
Revenue/Share
ROA -0.20040001
ROE -0.3406
grossProfits
freeCashflow -40.59M
operatingCashflow -80.38M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 393.04M
forwardPE -6.3615823
floatShares 34.22M
sharesOutstanding 56.43M
sharesShort 3.47M
sharesShortPriorMonth 4.01M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.99%
Short Ratio help_outline 7.40%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 4.584
Price To Book help_outline 2.46
earningsQuarterlyGrowth
netIncomeToCommon -93.24M
trailingEps -2.38%
forwardEps -1.77%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.42 3Q 2024
institutionsCount 152
lastUpdated Oct. 22, 2024, 12:56 a.m.